Monday, 13 March 2023

FDA approves new fast-acting nasal spray for migraines

The Food and Drug Administration on Friday approved Pfizer's nasal spray for migraines, giving patients access to a potentially fast-acting pain relief option.

from NBC News Top Stories https://ift.tt/UbonJLf

https://ift.tt/IA425xD

0 comments:

Post a Comment